Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Investing.com - Jefferies downgraded Clarivate Plc (NYSE:CLVT) from Buy to Hold on Friday, while lowering its price target to $4.50 from $5.20. The stock currently trades at $4.31, with InvestingPro analysis suggesting the company is undervalued despite recent challenges.
The downgrade comes despite Clarivate’s better-than-expected first-quarter 2025 results, with Jefferies expressing concern that investors are underestimating the timeline for management to unlock value through organic growth or divestitures.
Jefferies projects Clarivate’s 2026 revenues will remain roughly flat compared to 2025 levels, citing increased business risks from the current administration’s plans to reduce funding for the National Institutes of Health and post-secondary education.
The research firm also identified additional risks to Clarivate’s intellectual property business segment from artificial intelligence advancements, further complicating the company’s growth outlook.
While Jefferies acknowledges Clarivate’s "highly attractive" valuation, it expects the stock to trade sideways in the near term, justifying the Hold rating and reduced price target.
In other recent news, Clarivate Plc reported first-quarter results that exceeded analyst expectations, driven by accelerated recurring organic revenue growth. The company posted adjusted earnings per share of $0.14, surpassing the consensus estimate of $0.12, and reported revenue of $593.7 million, which was above the forecasted $577.45 million. Despite a 4.4% decline in total revenues due to inorganic divestitures and foreign currency impacts, recurring revenues saw a 0.6% organic increase compared to the previous year. Clarivate reaffirmed its full-year 2025 outlook, projecting adjusted EPS between $0.60 and $0.70 and anticipating organic annual contract value growth of 1.0% to 2.0%. In addition, the company generated $110.3 million in free cash flow during the first quarter and repurchased $50 million of ordinary shares. Meanwhile, Stifel analysts maintained their Buy rating on Clarivate stock with a $7.00 price target, citing the company’s recent strong performance. However, they noted that consistent performance across multiple quarters would be necessary to solidify investor confidence. Furthermore, at Clarivate’s 2025 Annual General Meeting, shareholders approved all proposals, including the election of directors and the authorization to repurchase ordinary shares.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.